Orthodontic Supplies Market
Orthodontic Supplies Market to Reach $12.4 Billion by 2030
[London, United Kingdom] – [1st June 2023] – The global orthodontic supplies market is projected to reach $12.4 billion by 2030, according to a new report by Pharmanucleus. The report, titled “Orthodontic Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,” provides an in-depth analysis of the market, including its drivers, restraints, opportunities, and challenges.
The market is driven by the increasing prevalence of malocclusions, rising awareness about the importance of orthodontic treatment, and growing demand for aesthetic orthodontic solutions. The rising adoption of digital orthodontics and the increasing popularity of clear aligners are also expected to drive the market growth.
However, the high cost of orthodontic treatment and the lack of access to orthodontic care in developing countries are expected to restrain the market growth.
The report segments the market by product type, material, end user, and region. By product type, the market is segmented into brackets, wires, bands, retainers, and other products. By material, the market is segmented into metal, ceramic, and clear aligners. By end user, the market is segmented into orthodontists, dentists, and hospitals.
The report also provides a competitive landscape of the market, including the market share of major players such as Align Technology, Dentsply Sirona, Henry Schein, American Orthodontics, and TP Orthodontics.
The report concludes with a SWOT analysis of the market and provides recommendations for the players operating in the market.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.